Carcinogenic responses of transgenic heterozygous p53 knockout mice to inhaled 239PuO2 or metallic beryllium

Toxicologic Pathology

Volumn 26, Issue 4, 1998, Pages 484-491

  Finch, Gregory L ^a,b   March, Thomas H ^a   Hahn, Fletcher F ^a   Barr, Edward B ^a   Belinsky, Steven A ^a   Hoover, Mark D ^a   Lechner, John F ^a   Nikula, Kristen J ^a   Hobbs, Charles H ^a  

^a Lovelace Biomedical and Environmental Research Institute   (United States)

^b LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

Author keywords

Acute exposure; Cancer incidence; Carcinogenesis; Inhalation exposure; Latency; Lung; Mice; P53 tumor suppressor gene; Pulmonary neoplasm; Survival; Transgenic

Indexed keywords

BERYLLIUM; PLUTONIUM DIOXIDE PU 239;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CARCINOGEN TESTING; CARCINOGENICITY; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; INHALATION; KNOCKOUT MOUSE; LUNG TUMOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE;

ANIMALIA; MUS MUSCULUS;

EID: 0031871369     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/019262339802600404     Document Type: Article

References (37)

1. Ashby J (1997). Identifying potential human carcinogens - The role of genetically altered rodents. Toxicol. Pathol. 25: 241-243.
2. Ashby J, Ishidate M Jr, Stoner GD, Morgan MA, Ratpan F, and Callander RD (1990). Studies on the genotoxicity of beryllium sulphate in vitro and in vivo. Mutat. Res. 240: 217-225.
3. Chen B, Liu L, Castonguay A, Maronpot RR, Anderson MW, and You M (1993). Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(nethylnitrosamino)-1-(3-pyridyl)-1-butanone induced mouse lung tumors. Carcinogenesis 14: 1603-1608.
4. Donehower LA, Harvey M, Slogle BL, McArthur MJ, Montgomery CA, Butel JS, and Bradley A (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 356: 215-221.
5. Dragan Y (1997). Minisymposium on emerging methods in cancer hazard identification. Toxicol. Pathol. 25: 238.
6. Environmental Protection Agency (1987). Health Assessment Document for Beryllium. EPA/600/8-84/026F. Washington, D.C.
7. Finch GL, Hahn FF, Griffith WC, Hoover MD, Carlton WW, Rebar AH, Mewhinney JA, and Cuddihy RG (1994). F344 rat lung carcinogenicity from inhaled beryllium metal. Toxicologist 14: 264 (abstract).
8. Finch GL, Haley PJ, Hoover MD, Snipes MB, and Cuddihy RG (1994). Responses of rat lungs to low lung burdens of inhaled beryllium metal. Inhalation Toxicol. 6: 205-224.
9. Finch GL, Hobbs C, Lundgren D, Benson J, Hahn F, Nikula K, Griffith W, Hoover M, Barr E, Belinsky S, Boecker B, and Mauderly J (1995). Worker risk issues for combined exposures to radionuclides and chemicals - An experimental toxicology approach. In: Environmental Restoration - 95 Proceedings, U.S. Department of Energy.
10. Greenblatt MS, Bennett WP, Hollstein M, and Harris CC (1994). Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res. 54: 4855-4878.
11. Haley PJ, Finch GL, Hoover MD, and Cuddihy RG (1990). The acute toxicity of inhaled beryllium metal in rats. Fundam. Appl. Toxicol. 15: 767-778.
12. Harvey M, McArthur MJ, Mongomery CA Jr, Butel JS, Bradley A, and Donehower LA (1993). Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat. Genet. 5: 225-229.
13. Harvey M, Vogel H, Norris D, Bradley A, Bernstein A, and Donehower LA (1995). A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice. Nat. Genet. 9: 305-311.
14. 1 mice. Carcinogenesis 14: 803-810.
15. Hoover MD and Mewhinney CJ (1985). Evaluation of a 96-port nose-only exposure chamber. In: Inhalation Toxicology Research Institute Annual Report 1984-1985, LMF-114, M Medinsky and B Muggenburg (eds). National Technical Information Service, Springfield, Virginia, pp. 41-44.
16. Hoover MD, Mewhinney JA, and Finch GL (1987). Generation and characterization of a beryllium metal aerosol for inhalation toxicity studies. In: Inhalation Toxicology Research Institute Annual Report 1986-1987, LMF-120, J Sun and J Mewhinney (eds). National Technical Information Service, Springfield, Virginia, pp. 45-49.
17. International Agency for Research on Cancer (1993). Beryllium, Cadmium, Mercury, and Exposures in the Glass Manufacturing Industry, Vol. 58, Lyon, France.
18. Kemp CJ, Wheldon T, and Balmain A (1994). p55-deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nat. Genet. 8: 66-69.
19. Keough RF and Powers GJ (1970). Determination of plutonium in biological materials by extraction and liquid scintillation counting. Anal. Chem. 42: 419-421.
20. 2. Radiat. Res. 111: 201-224.
21. Murray AB and Luz A (1990). Acidophilic macrophage pneumonia in laboratory mice. Vet. Pathol. 27: 274-281.
22. National Academy of Sciences and National Research Council, Committee on the Biological Effects of Ionizing Radiation (1988). Health Risks of Radon and Other Internally Deposited Alpha-Emit-ters. BEIR IV. National Academy Press, Washington, D.C.
23. Nickell-Brady C, Hahn FF, Finch GL, and Belinsky SA (1994). Analysis of k-ras, p53, and c-raf-1 mutations in beryllium-induced rat lung tumors. Carcinogenesis 15: 257-262.
24. Nikula KJ, Belinsky SA, Hoover MD, and Finch GL (1994). Comparative pulmonary carcinogenicity of inhaled beryllium in A/J and C3H/HeJ mice. In: Inhalation Toxicology Research Institute Annual Report 1993-1994, ITRI-144, SA Belinsky et al (eds). National Technical Information Service, Springfield, Virginia, pp. 81-83.
25. Nikula KJ, Belinsky SA, Hoover MD, and Finch GL (1995). Comparative pulmonary carcinogenicity of beryllium in A/J and C3H/ HeJ mice. Toxicologist 15: 47 (abstract).
26. Nikula KJ, Swafford DS, Hoover MD, Tohulka MD, and Finch GL (1997). Chronic granulomatous pneumonia and lymphocyte responses induced by inhaled beryllium metal in A/J and C3H/HeJ mice. Toxicol. Pathol. 25: 2-12.
27. Ootsuyama A, Makino H, Nagao M, Ochiai A, Yamauchi Y, and Tanooka H (1994). Frequent p53 mutations in mouse tumors induced by repeated beta-irradiation. Mol. Carcinog. 11: 236-242.
28. 2 and evaluation of gamma emitting labels. Health Phys. 28: 655-667.
29. Ruggeri B, DiRado M, Zhang SY, Bauer B, Goodrow T, and Klein-Szanto AJP (1993). Benzo[a]pyrene-induced murine skin tumors exhibit frequent and characteristic G to T mutations in the p53 gene. Proc. Natl. Acad. Sci. USA 90: 1013-1017.
30. Schwetz B (1997). Evolving picture of carcinogenicity evaluation within the food and drug administration. Toxicol. Pathol. 25: 239.
31. Snipes MB (1989). Long-term retention and clearance of particles inhaled by mammalian species. CRC Crit. Rev. Toxicol. 20: 175-211.
32. Tennant R (1997). Identifying carcinogens - A strategy for use of abbreviated models. Toxicol. Pathol. 25: 240-241.
33. Tennant RW, French JE, and Spalding JW (1995). Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models. Environ. Health Perspect. 103(10): 942-950.
34. Tennant RW, Spalding J, and French JE (1996). Evaluation of transgenic mouse bioassays for identifying carcinogens and noncarcinogens. Mutat. Res. 365: 119-127.
35. Tokarskaya ZB, Okladnikova ND, Belyaeva ZD, and Drozhko EG (1995). The influence of radiation and nonradiation factors on the lung cancer incidence among the workers of the nuclear enterprise Mayak. Health Phys. 69: 356-366.
36. Voelz GL and Lawrence JNP (1991). A 42-y medical follow-up of Manhattan Project plutonium workers. Health Phys. 61: 181-190.
37. Ward JM (1978). Pulmonary pathology of the motheaten mouse. Vet Pathol. 15: 170-178.